Flumazenil is a complete or partial reversal agent for benzodiazepines (receptor antagonist).

Prepare for the American Board of Pediatric Dentistry Oral Boards. Utilize flashcards and multiple-choice questions with hints and explanations to ace your exam!

Flumazenil acts as a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor. Benzodiazepines enhance GABA’s inhibitory effect, increasing chloride influx and producing sedation, respiratory depression, and decreased consciousness. By occupying that specific binding site, flumazenil blocks the benzodiazepine from exerting its effect, thereby reversing the sedation and respiratory depression without affecting other receptors.

This specificity is what makes it the correct choice for reversing benzodiazepine effects. Naloxone, in contrast, targets opioid receptors and reverses opioid-related effects, while morphine and meperidine are opioids themselves and would not counteract benzodiazepines. Keep in mind that flumazenil has a rapid onset but a relatively short duration, so repeat dosing may be needed if long-acting benzodiazepines are involved, and it can precipitate withdrawal or seizures in those with benzodiazepine dependence. It also won’t reverse effects from other CNS depressants like alcohol or barbiturates.